MAIA · MAIA Biotechnology Inc
United States · RS rating 25 · As of 2026-11-03
| Price | 1.08 USD |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 25 / 38 / 28 / 41 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 19 / 7 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +7.1% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +63.4% |
| Market cap (USD) | $76.4M |